February 27, 2020 / 12:46 PM / a month ago

BRIEF-Iveric Bio Reports Q4 Loss Per Share $0.39

Feb 27 (Reuters) - Iveric Bio Inc:

* IVERIC BIO REPORTS FOURTH QUARTER AND YEAR END 2019 OPERATIONAL HIGHLIGHTS AND FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.39

* SAYS ESTIMATES THAT ITS YEAR-END 2020 CASH AND CASH EQUIVALENTS WILL RANGE BETWEEN $60 MILLION AND $70 MILLION

* IVERIC BIO - CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS AND CAPITAL EXPENDITURE REQUIREMENTS AS CURRENTLY PLANNED INTO BEGINNING OF 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below